{"product_id":"9780323532365","title":"The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology\/Oncology Clinics of North America, E-Book","description":"This issue of Hematology\/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!","brand":"Elsevier Health Sciences","offers":[{"title":"Default Title","offer_id":47108457758960,"sku":"9780323532365","price":102.49,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/9780323532365_p0.jpg?v=1763683158","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/9780323532365","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}